Bernard, D., et al. (2013). "Radioiodine 131 therapy in hyperthyroidism Evaluation of
French nuclear medicine practice." European Journal of Nuclear Medicine andMolecular Imaging 40: S233.
Carhill, A., et al. (2011). "Surviving the storm." Thyroid 21: A84.
Cassar, M., et al. (2016). "Factors influencing management of Graves' disease." Irish
Journal of Medical Science 185: S164.
Chakrabarti, B. (2001). "Radio-iodine (NaI131) therapy in hyperthyroidism." Journal of
the Indian Medical Association 99(11): 642-645.
Chandran, S., et al. (2012). "Comparison of fixed low dose versus high dose radioactive
iodine (RAI) for the treatment of hyperthyroidism: Retrospective multifactorial analysis
impacting the outcome of therapy." European Journal of Nuclear Medicine and Molecular
Imaging 39: S340.

Claret-Torrents, C., et al. (2009). "Hyperthyroidism in Down síndrome." SD Revista
Medica Internacional sobre el Sindrome de Down 13(1): 2-8.
De Luca, F., et al. (2016). "Management of hyperthyroidism in children." Expert Review
of Endocrinology and Metabolism 11(4): 301-309.
Lee, L. K. and D. Q. Pham (2009). Pharmacotherapy of thyroid disorders in healthsystems. 75: 88-90.
Minamitani, K., et al. (2017). "Guidelines for the treatment of childhood-onset graves’disease in Japan, 2016." Clinical Pediatric Endocrinology 26(2): 29-62.
Mohanty, B. B., et al. (2012). "Goitre: A complete review." International Journal of
Pharma and Bio Sciences 3(3): B33-B48.
Portmann, L. (2001). "Therapeutical approach to hyperthyroidism." Medecine et Hygiene
59(2334): 350-356.

Rokni, H., et al. (2014). "Efficacy of different protocols of radioiodine therapy fortreatment of toxic nodular goiter: Systematic review and meta-analysis of the literature."International Journal of Endocrinology and Metabolism 12(2).
Ross, D. S., et al. (2016). "2016 American Thyroid Association Guidelines for Diagnosis
and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis." Thyroid26(10): 1343-1421.
Shah, N., et al. (2015). "Graves' disease and thymic hyperplasia." Endocrine Reviews 36.
Škrabic, V., et al. (2017). "Thyrotoxicosis in children and adolescents - Diagnostic andtherapeutic dilemmas." Paediatria Croatica 61(1): 1-9.
Stuss, M., et al. (2017). "The role of selenium in thyroid gland pathophysiology."
Endokrynologia Polska 68(4): 440-465.
Sundaresh, V., et al. (2012). "Comparative effectiveness of the therapeutic options forgraves' disease: A systematic review and network meta-analysis." Thyroid 22: A86-A87.
Suresh Kumar, A. C., et al. (2010). "Comparison of fixed low dose versus high doseradioactive iodine for the treatment of hyperthyroidism: Retrospective multifactorial
analysis impacting the outcome of therapy." Indian Journal of Nuclear Medicine 25(3):99-100.
Tamler, R. and J. I. Mechanick (2006). "Dietary supplements and nutraceuticals in the
management of endocrine disorders." Current Opinion in Endocrinology and Diabetes
13(5): 425-430.
Toft, A. D. (2013). "So we think we know how to treat Graves' disease." Journal of
Endocrinology, Metabolism and Diabetes of South Africa 18(1): 39.
van Isselt, J. W. and A. J. van Dongen (2004). "The current status of radioiodine therapy
for benign thyroid disorders." Hellenic Journal of Nuclear Medicine 7(2): 104-110.
Wilson, C. (2011). "Thyroid function: New guidance for the diagnosis and managementof thyroid diseases in pregnancy." Nature Reviews Endocrinology 7(10): 559.

Wilson, C. (2012). "Endocrine disorders in pregnancy: Updated guidelines for the
management of thyroid disorders in pregnancy." Nature Reviews Endocrinology 8(11):624.
Wong, J. and S. M. Wiseman (2015). "Thyroid surgery for treatment of Graves' disease
complicated by ophthalmopathy: A comprehensive review." Expert Review ofEndocrinology and Metabolism 10(3): 327-336.
Wright, H. V. and D. J. Williams (2013). "Thyrotoxicosis in pregnancy." Fetal andMaternal Medicine Review 24(2): 108-128.
Wysocki, J., et al. (2010). "Thyrotoxicosis induced cholestasis." American Journal of
Gastroenterology 105: S268.
Zhadina, M., et al. (2017). "Prognostic indicators of remission and relapse in children
with graves' disease after treatment with antithyroid drugs." Endocrine Reviews 38(3).
Zhu, H., et al. (2016). "The efficacy and safety of lithium carbonate in combination withradioactive iodine therapy of hyperthyroidism: A meta-analysis and systematic review."
International Journal of Clinical and Experimental Medicine 9(7): 12721-12728.
Deneke, D. E. and D. Ravindranath (2012). "Diagnosis and management of psychiatriccomorbidities in patients with hyperthyroidism: An updated review." Minerva
Psichiatrica 53(1): 39-46.

Derakhshan, S. and S. Shahsavari (2014). "Effect of oral anti-thyroid therapy on bonedensity in premenopausal women with endogenous subclinical hyperthyroidism."
Scientific Journal of Kurdistan University of Medical Sciences 19(3): 1-11.
Ferrer, E. and M. À. Moral (2007). "Graves' disease." Drugs of the Future 32(6): 555-561.
Giesecke, P., et al. (2017). "Increased Cardiovascular Mortality and Morbidity in Patients
Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter."Thyroid 27(7): 878-885.

Gullo, D., et al. (2017). "Seasonal variations in TSH serum levels in athyreotic patients
under L-thyroxine replacement monotherapy." Clinical Endocrinology 87(2): 207-215.
Hammonda, E. N. B. and M. D. T. H. W. Vangua (2016). "Lithium-enhanced radioactive
iodine ablation of hyperthyroid patients." Journal of Endocrinology, Metabolism andDiabetes of South Africa 21(3): 51-55.
Hope, N. and A. Kelly (2017). "Pre-operative Lugol's iodine treatment in the
management of patients undergoing thyroidectomy for graves' disease: A review of theliterature." European Thyroid Journal 6(1): 20-25.
Jha, C. K., et al. (2017). "Comment on article entitled “Randomized trial of a short courseof preoperative potassium iodide in patients undergoing thyroidectomy for Graves’disease”." American Journal of Surgery 213(6): 1194.
Kyrilli, A., et al. (2015). Thiamazole pretreatment lowers the 131I activity needed to cure
hyperthyroidism in patients with nodular goiter. 100: 2261-2267.
Mbodj, M., et al. (2009). "Contribution of radio-iodine 131 in the treatment of Grave's
Basedow disease in the department of nuclear medicine of Ibn Sina Hospital in Rabat."
Medecine Nucleaire 33(10): 592-598.
Miranda-Padua, M. L., et al. (2014). "A randomized double-blind comparison of fixedversus calculated radioiodine dose in the treatment of graves’ hyperthyroidism."Phillippine Journal of Internal Medicine 52(3).
Moleti, M., et al. (2014). "Radioiodine ablation of postsurgical thyroid remnants after
treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe
graves' orbitopathy (GO): A prospective, randomized, single-blind clinical trial." Journalof Clinical Endocrinology and Metabolism 99(5): 1783-1789.
Petersen, J. and K. W. Lin (2017). "Radioactive iodine therapy vs. Antithyroid
medications for Graves disease." American Family Physician 95(5): 292-293.
Stettner, D., et al. (2013). "Graves' disease and obstetric complications." Ginekologia i

Poloznictwo 29(3): 9-18.
Tepmongkol, S. (2002). "Enhancement of radioiodine uptake in hyperthyroidism withhydrochlorothiazide: A prospective randomised control study." European Journal of
Nuclear Medicine and Molecular Imaging 29(10): 1307-1310.
Wai, D. (2011). "Updates on the medical treatment for thyroid disease." Annals of the
Academy of Medicine Singapore 40(7): S14.
Wojtczak, B., et al. (2010). "State-of-the-art treatment of thyroid disorders with special
emphasis on surgery including minimally invasive techniques." Family Medicine andPrimary Care Review 12(4): 1059-1063.
Yilmaz, Y., et al. (2016). "The effect of preoperative Lugol's iodine on intraoperative
bleeding in patients with hyperthyroidism." Annals of Medicine and Surgery 9: 53-57.
Abiodun, A. O., et al. (2016). "Struck twice: An unusual case of graves' disease withthyrotoxicosis and diabetes insipidus in a previously healthy man." Journal of General
Internal Medicine 31(2): S738.
Abós, M. D., et al. (2000). "Treatment with 131I of toxic multinodular goiter. Assessmentof a fixed dose protocol." Revista Espanola de Medicina Nuclear 19(3): 182-186.
Abuchaibe, C., et al. (2014). "A case of thyroid storm following radioactive iodine (RAI):
Was it a consequence of RAI or withdrawal from Methimazol." Endocrine Reviews 35.
Ahmad, K., et al. (2017). "A deadly storm: Catastrophic thyroid storm with DIC andcardiomyopathy." American Journal of Respiratory and Critical Care Medicine 195.
Ahmadi, S. and L. D. K. St Clair (2012). "A case of autoimmune lymphocytic thyroiditis
causing thyroid storm." Endocrine Reviews 33(3).
Ahmed, R. and M. Djekidel (2012). "Multimodality imaging in staging of thyroid cancer."
Thyroid 22: A114-A115.
Akhtar, M. S., et al. (2002). "Radioactive iodine treatment in diffuse toxic goiter bycalculation of thyroid volume with ultrasonography." Medical Forum Monthly 13(7): 1922.
Akturk, H. K., et al. (2016). "Thyrotoxicosis with non-suppressed TSH: Diagnostic andtherapeutic trial of short acting octreotide in a patient with non-localizable TSHsecreting tumor." Endocrine Reviews 37(2).
Albu, S. E., et al. (2016). "Thyroid autoimmune disease: Between hypothyroidism andhyperthyroidism." Archives of the Balkan Medical Union 51(4): 483-487.
Al-Omari, A., et al. (2010). "Outcome of radioactive iodine treatment for hyperthyroidism.
Single centre experience." Rawal Medical Journal 35(1): 61-64.
Aminorroaya, A., et al. (2017). "Incidence of thyroid dysfunction in an Iranian adult
population: The predictor role of thyroid autoantibodies: Results from a prospective
population-based cohort study." European Journal of Medical Research 22(1).
Atmaca, A., et al. (2004). "Symptomatic treatment of Graves hyperthyroidism withlithium in states of thionamide adverse reactions: A retrospective analysis."
Endocrinologist 14(6): 317-320.
Azim, S. and C. Nasr (2016). "Hyperthyroidism due to functional metastatic papillary
thyroid cancer in a patient with graves' disease; a diagnostic and management dilemma."
Thyroid 26: A96.
Azorín Belda, M. J., et al. (2017). "Recombinant human thyrotropin stimulation prior to
131I therapy in toxic multinodular goitre with low radioactive iodine uptake." Revista
Espanola de Medicina Nuclear e Imagen Molecular 36(1): 7-12.
Babiker, A., et al. (2014). "Genetic susceptibility in autoimmune polyglandular syndrome
type 3 variant." Hormone Research in Paediatrics 82: 271.
Bajuk, V., et al. (2017). "Effects of Adequate Iodine Supply on the Incidence of IodineInduced Thyroid Disorders in Slovenia." Thyroid 27(4): 558-566.
Balaguruswamy, S. and S. Jones (2009). "Audit on the management of thyrotoxicosis inthe clinic at a District General Hospital." Endocrine Abstracts 19: P385.
Balakrishnan, V., et al. (2013). "Marine-lenhart syndrome with a malignant
hyperfunctioning nodule-a rare presentation of a rare syndrome." Thyroid 23: A106.
Bastan-Hagh, M. H., et al. (2006). "Treatment of 1035 hyperthyroid patients with
131Iodine." International Journal of Pharmacology 2(1): 116-120.
Bazrafshan, H. R., et al. (2011). "Low-dose anti-thyroid medication in graves disease:
Assessment of the efficacy based on a long-term follow-up (interim report)." Endocrine
Reviews 32(3).
Benjamin, J. S., et al. (2011). "Thyrotoxicosis in the premature infant." Journal of
Investigative Medicine 59(2): 451.
Bham, F. (2017). "Molar pregnancies with a focus on the thyroid." Southern African
Journal of Anaesthesia and Analgesia 23(2): 7-11.
Bilir, P., et al. (2015). "Angioneurotic oedema with antithyroid drugs in thyroid storm:
What is the best therapeutic option." Hormone Research in Paediatrics 84: 571-572.
Boelaert, K., et al. (2010). "Induction of hypothyroidism with radioactive iodine therapy
is associated with improved survival in patients with hyperthyroidism." Endocrine
Abstracts 21: OC5.4.
Borremans, C. G. and H. A. Perinetti (2003). "Pregnancy and thyroid diseases." Prensa
Medica Argentina 90(3): 232-243.
Bothra, N., et al. (2017). "Hashimoto's thyroiditis: relative recurrence risk ratio andimplications for screening of first-degree relatives." Clinical Endocrinology 87(2): 201206.
Brown, C. H. (2016). Antithyroid medications for graves’ disease. 41: HS14-HS18.
Buddhadev, P. and M. S. Shah (2013). "Coma: Hyperthyroid or hypothyroid." Journal of
General Internal Medicine 28: S310.

Bui, P. V., et al. (2016). "Sanguineous pericardial effusion and cardiac tamponade in thesetting of graves' disease: Report of a case and review of previously reported cases." Case
Reports in Medicine 2016.
Bulmus, N., et al. (2013). "Thyroid diseases in pregnancy: The importance of anamnesis."
Pakistan Journal of Medical Sciences 29(5): 1187-1192.
Cai, X. and S. Bhushan (2015). "Amiodarone induced toxicity." Journal of General
Internal Medicine 30: S356.
Calissendorff, J. and H. Falhammar (2017). "Rescue pre-operative treatment with
Lugol’s solution in uncontrolled Graves’ disease." Endocrine Connections 6(4): 200-205.
Carluccio, A. L., et al. (2012). "Apatjetoc thyrotoxicosis secondary to atypical subacutethyroiditis." Endocrine Practice 18(5): e127-e129.
Catania, A., et al. (2013). "Total thyroidectomy for Graves' disease treatment." Clinica
Terapeutica 164(3): 193-196.
Cebulska-Wasilewska, A., et al. (2017). "Retrospective biological dosimetry at low andhigh doses of radiation and radioiodine impact on individual susceptibility to ionizing
radiation." Genome Integrity 8(1).
Chandrasekera, H., et al. (2013). "A resistant case of thyrotoxicosis in a patient withgraves' disease." Endocrine Reviews 34(3).
Chang, R. Y. K., et al. (2014). "Evaluating the efficacy of primary treatment for graves'disease complicated by thyrotoxic periodic paralysis." International Journal of
Endocrinology 2014.
Chow, T. L., et al. (2003). "Surgical treatment of thyrotoxicosis: A local institution's
perspective." Annals of the College of Surgeons of Hong Kong 7(1): 29-33.
Clark, C. and C. Knight (2016). "Relapsing thyrotoxicosis after total thyroidectomy in apatient with graves' disease." Journal of General Internal Medicine 31(2): S717-S718.

Clarke, S. E. M. and S. C. Rankin (2002). "The thyroid gland." Imaging 14(2): 103-114.
•
Cohn, A., et al. (2017). "Radioactive iodine treatment for hyperthyroidism in a patientwith end stage renal disease." Endocrine Reviews 38(3).
Coleman-Pierron, R., et al. (2015). "Stopping the storn, when thyroid storm requires
plasmapheresis." Journal of Investigative Medicine 63(2): 358.
Concepcion, J., et al. (2015). "Rapid recovery of ANC after using GCSF to treat doserelated methimazole-induced agranulocytosis in a pediatric graves' disease patient."
Endocrine Reviews 36.
Cramon, P., et al. (2016). "Quality-of-Life Impairments Persist Six Months after
Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort
Study." Thyroid 26(8): 1010-1018.
Cury, A. N., et al. (2013). "Clinical experience with radioactive iodine in the treatment ofchildhood and adolescent Graves' disease." Endocrine Connections 2(1): 32-37.
Damle, N., et al. (2010). "Is low radioactive iodine uptake really an adverse factor in theoutcome of radioiodine therapy of Graves disease?" Journal of Nuclear Medicine 51.
Dardi, I. K., et al. (2015). "A case of hypothyroidism in a cat owner with methimazole use
for the treatment of feline hyperthyroidism." Thyroid 25: A66.
Darwish, S. M., et al. (2009). "Success rate of radioiodine treatment of hyperthyroidism
in Qatari patients." Qatar Medical Journal 18(1): 42-46.
Das, B. K., et al. (2006). "Rational management of differentiated thyroid cancer."
Malaysian Journal of Medical Sciences 13(2): 45-51.
Dasari, R., et al. (2011). "Amiodarone induced thyrotoxicosis: A challenging clinicalsituation." Thyroid 21: A52.
Davidenko, I., et al. (2012). "Unmarked case of amiodarone-induced thyrotoxicosis."European Thyroid Journal 1: 133.
Dede, F., et al. (2011). "Comparison of fixed 10 mCi and 15 mCi iodine-131 doses for thetreatment of graves' disease: 11 year study." Marmara Medical Journal 24(1): 26-30.
Dejax, C., et al. (2005). "Iodine-131 treatment of hyperthyroidism in the elderly. Resultsin 180 patients. Radioprotection and waste management in 131-iodine therapy."
Medecine Nucleaire 29(9): 609-619.
.
Del Rivero, J. and F. S. Celi (2013). "An uncommon serious adverse event associated withsaturated solution of potassium iodide (SSKI) treatment." Endocrine Reviews 34(3).
Demirel, K., et al. (2011). "Outcome of radioiodine therapy in patients withhyperthyroidism: Calculated doses vs. Fixed doses." European Journal of Nuclear
Medicine and Molecular Imaging 38: S431-S432.
Dhillon, A. K., et al. (2016). "Post CABG thyroid storm: A near miss." Endocrine Reviews
37(2).
Dhingra, V. K. and N. Bhatia (2015). "Use of telemedicine for facilitation of follow-up ofpatients of hyperthyroidism after definitive therapy with radioiodine in a primarily hilly
state." Indian Journal of Nuclear Medicine 30(5): S27.
Dimakopoulou, A., et al. (2015). "Stress cardiomyopathy (Takotsubo) following
radioactive iodine therapy." Endocrinology, Diabetes and Metabolism Case Reports 2015.
Dodig, D., et al. (2003). "Treatment of Graves' disease with radioiodine (I131)."
Paediatria Croatica, Supplement 47(1): 113-116.
Donepudi, I., et al. (2012). "Acute cholestatic liver disease secondary to propylthiouracil
and hyperthyroid cardiomyopathy in patient with grave's disease." American Journal of
Gastroenterology 107: S446-S447.
Ecker, J. L. and T. J. Musci (2000). "Thyroid function and disease in pregnancy." Current
Problems in Obstetrics, Gynecology and Fertility 23(3): 109-122.

Left untreated during pregnancy, thyroid disease is associated with maternal
and neonatal morbidity. However, treated patients can expect pregnancy outcomes nodifferent than those of euthyroid patients. In order to manage therapy for pregnant
patients with thyroid disorders, it is important to first understand the changes in thyroid
anatomy, physiology, and testing expected in uncomplicated pregnancies. With thisinformation in hand, practitioners can adjust pharmacologic therapy to minimize fetal
complications and avoid undertreating or overtreating mothers.
Edinboro, C. H. (2011). "A “one medicine” example: Humans as the model for a feline
disease." Thyroid 21: A37.
El Bez, I., et al. (2014). "Iodine-131 treatment of hyperthyroidism in people older than
65 years." European Journal of Nuclear Medicine and Molecular Imaging 41: S547.
El Issami, S., et al. (2011). "Treatment of hyperthyroidism with iodine-131: A propos of
280 cases." Medecine Nucleaire 35(10): 528-532.
Eliades, M., et al. (2014). "Thyroid storm induced by electrical shock delivered by a Tasergun." Endocrine Reviews 35.
Eniojukan, J. F. and A. O. Adepoju (2014). "Evaluating the effects of anti-thyroid drugs
and thyroidectomy in patients receiving radioactive iodine therapy for graves'
hyperthyroidism-a retrospective study from a University Teaching Hospital in South
West, Nigeria." Value in Health 17(7): A741.
Eugenio, F., et al. (2016). "Retrospective analysis of thyroid function tests in patientswith grave's disease treated with protocol-based dosing of methimazole in a safety-net
endocrinology clinic." Endocrine Reviews 37(2).
Fatourechi, V. (2000). "Medical treatment of graves' ophthalmopathy." Ophthalmology
Clinics of North America 13(4): 683-691.
Führer, D. (2016). "Thyroid disorders: Diagnosis and therapeutic approaches 2015."
LaboratoriumsMedizin 40(1): 1-10.
Gaberscek, S., et al. (2014). "Characteristics of iodine-induced thyroid disorders after anincrease in mandatory salt iodization." European Journal of Nuclear Medicine andMolecular Imaging 41: S566.
Gambardella, V., et al. (2003). "Thyroid diseases in pregnancy." Giornale Italiano di
Ostetricia e Ginecologia 25(9): 361-367.
Ganjoo, N. and V. Puthi (2016). "Primary cutaneous amyloidosis in an adolescent withgraves' disease: Previously unknown association." Archives of Disease in Childhood 101:
A278-A279.
Garg, N., et al. (2013). "Calming the storm - Role of plasmapheresis in thyrotoxic crises."
Endocrine Reviews 34(3).
Gavilán Villarejo, I., et al. (2012). "Hyperthyroidism." Medicine (Spain) 11(14): 813-818.
Gessl, A., et al. (2012). Thyroid disorders. 214: 361-386.

Gianotti, R. (2012). "Riding the storm: A rare cause of acute liver failure." Journal of
Hospital Medicine 7: S188-S189.
Gonzalez-Bossolo, A., et al. (2016). "Cerebrovascular Accident due to Thyroid Storm:
Should We Anticoagulate?" Case Reports in Endocrinology 2016.
Greeve, J. (2003). "Thyroid disorders during pregnancy." Gynakologe 36(11): 965-973.
Gu, Y., et al. (2016). "Pulmonary hypertension aggravated by hyperthyroidism: A casereport." Endocrine Reviews 37(2).
Guerra, Y. S., et al. (2012). "Bedside ultrasound use in graves disease." Endocrine
Reviews 33(3).
Gulati, K., et al. (2010). "What is the influence of rheumatologic conditions on response
to medical therapy of Graves' disease?" Irish Journal of Medical Science 179(13): S513.
Hakami, O., et al. (2016). "A case of nonfatal ventricular arrhythmia due to thyrotoxic

periodic paralysis in a Saudi patient as an initial presentation of Graves’ disease."
Clinical Medicine Insights: Case Reports 9: 5-9.
Harari, A., et al. (2011). "Quality of life assessment in pediatric Graves' disease patients
after treatment with surgery versus radioactive iodine (a pilot study)." Thyroid 21: A51.
Harrasser, M., et al. (2013). "Neonatal thyrotoxicosis-potentially life-threatening!" Swiss
Medical Weekly 143: 36S.
Heringer, L. and H. Crevensten (2010). "Recurrent paralysis due to hyperthyroidism
causing hypokalemia." Journal of General Internal Medicine 25: S544-S545.

Holt, S. C. and N. Morone (2017). "Hey doc, I amlosingweight: A 30 pound weight loss inan African American male." Journal of General Internal Medicine 32(2): S509.
Iglesias, P. (2007). "Effects of amiodarone therapy on thryoid function and its current
management." Endocrinologia y Nutricion 54(7): 354-370.
Ivanova, I. V., et al. (2016). "The use of lithium in the treatment of resistant Graves'
Thyrotoxicosis." Endokrinologya 21(3): 167-175.

Iwasaki, H. (2015). "Onset of graves’ disease during long-term immunosuppressive
therapy in a patient with membranous nephropathy." Endocrinology, Diabetes andMetabolism Case Reports 2015.
Izkhakov, E., et al. (2016). "Drug versus radioactive treatment of graves' diseasemetabolic outcomes." Endocrine Reviews 37(2).
Jain, M., et al. (2013). "Methimazole-induced concomitant agranulocytosis andhepatotoxicity." Endocrine Reviews 34(3).
Jevalikar, G., et al. (2013). "Long-term outcomes of paediatric Graves disease." Hormone
Research in Paediatrics 80: 358.

Jiang, N., et al. (2015). "Follow-up and evaluation of the pregnancy outcome in womenat reproductive age with graves'hyperthyroidism after 131-iodine treatment." Thyroid
25: A79.
Johnston, N., et al. (2014). "Neonatal thyrotoxicosis in maternal grave's disease: A caseseries and review of the literature." Hormone Research in Paediatrics 82: 460-461.
Johnston, N. F., et al. (2014). "Neonatal thyrotoxicosis: A case series." Irish Journal of
Medical Science 183(4): S141.
Johnstone, H. C., et al. (2004). "The evaluation and management of thyrotoxicosis."Current Paediatrics 14(5): 430-437.

Journy, N. M. Y., et al. (2017). "Hyperthyroidism, Hypothyroidism, and Cause-Specific
Mortality in a Large Cohort of Women." Thyroid 27(8): 1001-1010.
Jowkar, F. and F. Sari Aslani (2007). "Elephantiasic pretibial myxedema." Journal of
Pakistan Association of Dermatologists 17(3): 187-189.
Kalk, W. J. and M. D. T. H. Vangu (2002). "Non-toxic multinodular goitres." Journal of
Endocrinology, Metabolism and Diabetes of South Africa 7(1): 10-13.
Kamoun, T., et al. (2013). "Factors influencing the success of Radio-iodine dose in thetreatment of Graves disease: One year outcom." European Journal of Nuclear Medicine
and Molecular Imaging 40: S232.
Kampmann, E., et al. (2014). "Thyroid stimulating but not blocking autoantibodies arehighly prevalent in active/severe thyroid-associated orbitopathy-a prospective study."
Thyroid 24: A10.
Kara, O., et al. (2013). "A case with Graves disease who developed agranulocytosis andvasculitis during metimazole treatment." Hormone Research in Paediatrics 80: 441.
Kaufman, L. and L. Zimmerman (2003). "Thyrotoxicosis and thyroid storm - A review of
evaluation and management." Primary Care Update for Ob/Gyns 10(1): 29-32.

Khan, S. H., et al. (2017). "Radioactive iodine-131 as a definitive treatment in rareassociation of down syndrome with hyperthyroidism: A case report and review ofliterature." Indian Journal of Nuclear Medicine 32(1): 19-24.
Kienitz, T., et al. (2007). "Long-term management in five cases of TSH-secreting pituitaryadenomas: A single center study and review of the literature." European Journal of
Endocrinology, Supplement 157(1): 39-46.
Kim, Y. A., et al. (2016). "Long-term clinical course after antithyroid drug treatment inpatients with graves' disease." Endocrine Reviews 37(2).
Koh, Z. Y., et al. (2016). "Thyroid storm precipitated by cerebral venous thrombosis."
Endocrine Reviews 37(2).
Korula, S., et al. (2015). "Graves' disease in children less than 8 years of age: Review ofclinical features and treatment outcome." International Journal of PediatricEndocrinology 2015.
Kudugunti, N., et al. (2013). "An intriguing case of hypothyroid woman becoming
hyperthyroid." European Thyroid Journal 2: 133.

Kwok, C., et al. (2004). "Standard-dose prescription of radioiodine therapy forthyrotoxicosis: The Queen Mary Hospital experience." Journal of the Hong Kong Collegeof Radiologists 7(4): 187-194.
Kyrilli, A., et al. (2013). "Thiamazol increases iodine uptake and allows a reduction ofradioiodine dose needed to treat subclinical hyperthyroidism in patients withmultinodular goiter." European Thyroid Journal 2: 145.
La Cour, J. L., et al. (2016). "Radioiodine Therapy Does Not Change the Atherosclerotic
Burden of the Carotid Arteries." Thyroid 26(7): 965-971.
Ladenheim, S., et al. (2009). "Medical treatment evaluation in patients with Graves
Basedow disease in relation to indicators of unsatisfied basic needs." Revista Argentina

de Endocrinologia y Metabolismo 46(2): 3-10.
Lai, J. and V. Wong (2017). "Urinary iodine as a predictor of lag-time to hypothyroidismin patients treated with iodine-131 for grave's disease." Clinical Endocrinology 86: 35-36.

Larijani, B., et al. (2002). "Treatment of hyperfunctioning thyroid nodules by
percutaneous ethanol injection." BMC Endocrine Disorders 2.
Leighton, K. and N. Priddee (2017). "The disappearing haemoglobinopathy trait." British
Journal of Haematology 176: 102.
Leïla, E., et al. (2015). "Hyperthyroidism in children and adolescents: Causes, when andhow to treat-a Tunisian experience." Hormone Research in Paediatrics 84: 564.
Leung, B. C. H. (2003). "Management of thyroid nodules." Hong Kong Practitioner
25(12): 611-615.
Lithgow, K. and C. Symonds (2017). "Severe Thyrotoxicosis Secondary to PovidoneIodine from Peritoneal Dialysis." Case Reports in Endocrinology 2017.
Liu, M., et al. (2016). "The perfect storm: Fever, tachycardia, and altered mental status
after PTCA." Journal of General Internal Medicine 31(2): S756.
Madhushanka, J. K. V., et al. (2013). "Malignant struma ovarii, a case of papillary
thyroid carcinoma in ovary." BJOG: An International Journal of Obstetrics andGynaecology 120: 233-234.
Mahapatra, A. and M. Sood (2015). "Hyperthyroidism on long-term lithium carbonate
therapy: A case report." Indian Journal of Psychiatry 57(5): S142-S143.
Maraka, S., et al. (2012). "New onset graves disease after radioactive iodine treatmentof toxic multinodular goiter." Endocrine Reviews 33(3).
Marcocci, C., et al. (2010). "Selenium and pentoxifylline in patients with mild Graves'
orbitopathy: Results of a randomized placebo-controlled double-blind clinical trial."

Endocrine Abstracts 22: P866.
Marley, J. and R. Comi (2012). "A case of lithium treatment preceding onset of graves
disease: Effects on presentation and radionuclide studies." Endocrine Reviews 33(3).
Marques, O., et al. (2014). "Treatment of pediatric graves' disease: Results of amulticenter survey in portugal." Hormone Research in Paediatrics 82: 309-310.
Marrec, C., et al. (2013). "Amiodarone-induced thyrotoxicosis: A rare complication inchildren." Hormone Research in Paediatrics 80: 363.
Matsumoto, M., et al. (2013). "Predictors of recurrence of graves' disease after medical
treatment." Thyroid 23: A101.
We
McCombe, P., et al. (2014). "Pregnancy outcomes in the alemtuzumab MS clinicaldevelopment program." Multiple Sclerosis 20(1): 436-437.
McCormack, A. I. and D. L. Learoyd (2006). "A guide to thyroid dysfunction." Medicine
Today 7(5): 28-35.
Medina, N. and C. Shah (2014). "Iatrogenic thyroid storm in apathetic hyperthyroidism:
An unpleasant experience." American Journal of Respiratory and Critical Care Medicine
189.
Meller, J., et al. (2002). "Radioiodine-treatment (RIT) of functional thyroidal autonomy."
Nuclear Medicine Review 5(1): 1-10.
Memmott, R. M. and V. Chockalingam (2015). "Presentation, diagnosis, and emergent
management of a patient with thyrotoxicosis, papillary thyroid carcinoma, and primaryand secondary hyperparathyroidism." Endocrine Reviews 36.
Mihailović, J. (2006). "Current concepts of 131I therapy in oncology: Indications,
methods and follow up." Archive of Oncology 14(1-2): 45-51.
Minamitani, K., et al. (2011). "A report of three girls with antithyroid drug-induced
agranulocytosis; retrospective analysis of 18 cases aged 15 years or younger reportedbetween 1995 and 2009." Clinical Pediatric Endocrinology 20(2): 39-46.
Mitra, S. and S. Muthu (2012). "Reduction in relapse rate of radioiodine therapy inpatients of toxic multinodular goiter: A quality improvement project." Indian Journal of
Nuclear Medicine 27(1): 5-9.
Momotani, N. and S. Iwama-Carlson (2015). "Resemblance and diversity of the activityof graves' disease seen in monozygotic female twins over the course of 20 years." Thyroid
25: A63.

Mousa, U., et al. (2017). "Aggravated orbitopathy following remnant ablation in a patientwith multiple cancers." Turkish Journal of Endocrinology and Metabolism 21(3): 81-84.
Musa, F., et al. (2013). "Unexplained tachycardia." Journal of Investigative Medicine
61(2): 399-400.
Naber, T. H., et al. (2010). "Reactive thyrotoxicosis: Under diagnosed complication ofparathyroidectomy in the dialysis population." American Journal of Kidney Diseases
55(4): A82.
Nacpil, P. D. and C. M. Sison (2012). "Psychosis in hyperthyroidism." Endocrine Reviews
33(3).
Naji, P., et al. (2013). "Graves' disease causing pancytopenia and autoimmune hemolytic
anemia at different time intervals: A case report and a review of the literature." Case
Reports in Medicine 2013.
Nakatake, N., et al. (2011). "Prediction of post-treatment hypothyroidism using changes
in thyroid volume after radioactive iodine therapy in adolescent patients with Graves'disease." International Journal of Pediatric Endocrinology 2011(1).
Nandiwada, D. R. and A. A. Chang (2012). "Plasmaphoresis in thyroid storm with multiorgan failure." Journal of General Internal Medicine 27: S467.
Negro, R., et al. (2016). "A 2015 Italian Survey of Clinical Practice Patterns in theManagement of Graves' Disease: Comparison with European and North American
Surveys." European Thyroid Journal 5(2): 112-119.
Nimmy, N. J., et al. (2010). "Prevalence of thyroid disorders in coastal, non-coastal,
midland and hilly areas of Kerala along with the toxicities due to treatment." Indian
Journal of Pharmaceutical Sciences 72(2): 282.
Niwattisaiwong, S. (2013). "Subacute thyroiditis misdiagnosed as graves' disease
resulting in severe hypothyroidism." Endocrine Reviews 34(3).
Nunes, J., et al. (2014). "Predictive factors of radioactive iodine therapy failure in graves'disease." European Thyroid Journal 3: 143.
Oh, S. Y., et al. (2017). "Chylothorax associated with substernal goiter in Graves' disease
treated with radioactive iodine." International Journal of Endocrinology and Metabolism
15(2).
Ohye, H., et al. (2012). "Antithyroid drug treatment for graves' disease in children: A
retrospective study at a single institution." Thyroid 22: A17-A18.
Ozkaya, H. M., et al. (2015). "An unusual cause of life threatening hypercalcemia due tothe grave's disease and concomitant addisonian crisis." Endocrine Reviews 36.
Palitzsch, K. D. (2017). "Thyroid disease in old age." Internistische Praxis 58(1): 51-64.
Pallavi, R., et al. (2013). "Thyrotoxicosis and acute liver failure." Critical Care Medicine
41(12): A325.
Par, J., et al. (2009). "The management of massive goitre in a DGH." Endocrine Abstracts
19: P360.
Peretianu, D., et al. (2010). "Drug induced hyperthyroidism (a rare reaction of sorafenib):
Case report." Endocrine Abstracts 22: P851.
Podugu, A., et al. (2014). "A rare case of fatal thyroid storm (TS) resulting in DIC andmultiorgan failure." Chest 146(4).

Polak, M. (2001). "Fetal hyperthyroidism: Mechanisms, investigations, treatment andconsequences for the child." Reproduction Humaine et Hormones 14(10): 683-689.
Pollak, P. and N. Vijayaratnam (2014). "Large geographic differences in prevalence ofhyperthyroidism observed in patients exposed to amiodarone." Clinical Pharmacology
and Therapeutics 95: S96-S97.
Pollak, P. T. and N. Vijayaratnam (2013). "Unusually high rate of hyperthyroidism
observed in patients exposed to amiodarone in calgary." Canadian Journal of Cardiology
29(10): S186.
Proenca, M., et al. (2013). "Prognostic value of subclinical hyperthyroidism in an internal
medicine ward." European Journal of Internal Medicine 24: e102.
Puig, G. D., et al. (2015). "Should we revisit anticoagulation guidelines during thyroid
storm?" Journal of Investigative Medicine 63(2): 332.
Rabon, S., et al. (2016). "Graves' disease in children: Long-term outcomes of medical
therapy." Clinical Endocrinology.
Rakov, H., et al. (2014). "Molecular mechanisms of sexdependent thyroid hormone action
on target tissues." European Thyroid Journal 3: 203.
Rakov, H., et al. (2014). "Molecular mechanisms of sex-dependent thyroid hormone action
on target tissues." Experimental and Clinical Endocrinology and Diabetes 122(3).
Rehman, A. U., et al. (2017). "Amiodarone-induced hyperthyroidism in patients withheart failure with and without a left ventricular assist device." Endocrine Reviews 38(3).
Rehman, S. U., et al. (2006). "Goiter in older adults." Aging Health 2(5): 823-831.
Ren, S. C., et al. (2016). "Von Willebrand factor and coagulation factor VIII in Moyamoya
disease associated with graves' disease: A case report." Experimental and Therapeutic
Medicine 12(5): 3195-3200.

Ridella, M., et al. (2010). "Iodine induced thyrotoxicosis in a patient with coronary arterydisease." Journal of Investigative Medicine 58(2): 390.
Rivera, L., et al. (2014). "Dangerous weight loss: A case report." Endocrine Reviews 35.
Rojas, C., et al. (2015). "Demografic and clinical characteristics of Graves' disease at apediatric hospital during the period 2004-2014." Hormone Research in Paediatrics 84:
60.
Ross, I. L., et al. (2005). "Amiodarone-induced thyroid dysfunction." Journal of
Endocrinology, Metabolism and Diabetes of South Africa 10(1): 6-9.
Rossodivita, A., et al. (2010). "Grave's disease in a girl with Gitelman's syndrome."
Hormone Research in Paediatrics 74: 289-290.

Rutecki, G. W. (2005). "What happens down the road to patients treated with radioactive
iodine?" Consultant 45(13): 1442.
Could RAI Rx ultimately be hurting your patients? Here: Reassuring new
evidence.
Ryödi, E., et al. (2015). "Cancer incidence and mortality in patients treated either withRAI or thyroidectomy for hyperthyroidism." Journal of Clinical Endocrinology andMetabolism 100(10): 3710-3717.
Saeed Akhtar, M., et al. (2002). "Radioactive iodine treatment in diffuse toxic goiter by
calculation of thyroid volume with ultrasonography." Journal of the College of Physiciansand Surgeons Pakistan 12(8): 477-480.
Saeedinia, S., et al. (2013). "Evaluation of anti-thyroid drugs, radioactive iodine andsurgery in patients with hyperthyroidism." Iranian Journal of Endocrinology andMetabolism 14(6): 1-8.
Samanta, P., et al. (2014). "Thyroid storm in a patient presenting with pulmonary
embolism and splenic infarct." American Journal of Respiratory and Critical Care

Medicine 189.
Sanchez, L. M. P., et al. (2013). "Clinical presentation and response to therapy of graves'disease in a multi-ethnic endocrine clinic." Endocrine Reviews 34(3).
Sanyal, D. and S. Chatterjee (2015). "Hyperthyroidism in children: Treatment outcomesand preferences in Eastern India." Clinical Pediatric Endocrinology 24(2): 63-66.
Sarma, D. and S. Gadve (2013). "Nodularity in graves' disease in the postiodization era:
Iodine status, thiocyanate exposure and autoimmunity." Endocrine Reviews 34(3).
Saumoy, M., et al. (2012). "Hyperbilirubinemia as a presenting symptom of thyrotoxicosis
in a patient with sickle cell disease." American Journal of Gastroenterology 107: S422.
Schindler, A. E. (2003). "Thyroid, Climacterium and Hormone Therapy." Journal fur
Menopause 10(4): 27-31.

Schneider, M., et al. (2016). "Clinical experience with radioactive iodine in treatment ofchildhood and adolescent graves' disease." Hormone Research in Paediatrics 86: 43.
Sekulic, V., et al. (2013). "Influence of smoking associated with stress on the outcome ofradioiodine therapy in patients with Graves' disease." European Journal of Nuclear
Medicine and Molecular Imaging 40: S401.
Sekulić, V., et al. (2015). "Cigarette smoking has no impact on the effect of radioiodine
therapy in patients with graves disease." Acta Facultatis Medicae Naissensis 32(1): 6775.
Shah, V. H. (2003). "Reader's Forum - 30." Indian Journal of Otolaryngology and Headand Neck Surgery 55(2): 145-146.
Shaikh, I. and A. Varanasi (2015). "A case of acute thyroiditis following therapy with
topical cadexomer iodine (iodosorb) ointment." Thyroid 25: A78-A79.

Shehata, N., et al. (2015). "Rare malignant struma ovarii - non-papillary thyroid
carcinoma of the ovary." BJOG: An International Journal of Obstetrics and Gynaecology
122: 151-152.
Sheng, S. W., et al. (2012). "Clinical features and efficacy of 131I remnant ablation ofdifferentiated thyroid carcinoma complicated with hyperthyroidism." Journal of
Shanghai Jiaotong University (Medical Science) 32(1): 83-84+89.
Shinall, M. C., et al. (2012). "Total thyroidectomy for graves' disease: A contemporary
series of 165 patients." Thyroid 22: A54.
Shobab, L., et al. (2016). "Methimazole-induced agranulocytosis in a newly diagnosed
graves's disease." Thyroid 26: A150.
Singh, G., et al. (2017). "Hypokalemia complicating new onset T1DM with DKA andsimultaneous thyrotoxic periodic paralysis." Endocrine Reviews 38(3).
Singh, M., et al. (2016). "Propylthiouracil induced fulminant hepatic failure." Endocrine
Reviews 37(2).
Singh, P., et al. (2009). "An audit of thyroid surveillance in amiodarone treated subjects- Room for improvement." Endocrine Abstracts 19: P95.
Skanjeti, A., et al. (2014). "Is radioiodine uptake test essential to treat hyperthyroidism
from solitary thyroid nodule?" European Journal of Nuclear Medicine and Molecular
Imaging 41: S543.
Smith, D. M., et al. (2016). "Change in Practice over Four Decades in the Managementof Graves' Disease in Scotland." Journal of Thyroid Research 2016.
Subramanian, M., et al. (2016). "The effect of prior antithyroid drug use on delaying
remission in high uptake Graves’ disease following radioiodine ablation." Endocrine
Connections 5(1): 34-40.
Sundaragiri, P., et al. (2013). "How to see a big 'k' drop!" Journal of General Internal
Medicine 28: S340-S341.

Sundaresh, V., et al. (2012). "Comparative effectiveness of treatment choices for graves'
hyperthyroidism: Experience of a tertiary referral center." Thyroid 22: A87.
Sundaresh, V., et al. (2013). "Comparative effectiveness of treatment choices for graves'disease in the elderly population: Experience of a tertiary referral center." Endocrine
Reviews 34(3).
Sundaresh, V., et al. (2017). "Comparative Effectiveness of Treatment Choices for Graves'
Hyperthyroidism: A Historical Cohort Study." Thyroid 27(4): 497-505.
Taïeb, D., et al. (2009). "Radioactive iodine ablation of Graves'disease." Medecine
Nucleaire 33(5): 314.
Takamura, T., et al. (2017). "Thyroid hormone represses the activation of NFκB pathway
and ameliorates kidney injury." Nephrology Dialysis Transplantation 32: iii437.
Tamam, M., et al. (2014). "Radioiodine therapy for hyperthyroidism in a patient with
end-stage renal disease on hemodialysis: Case report." Medical Journal of Bakirkoy
10(2): 75-77.
Tareq, S. H., et al. (2013). "Hallucinations as presenting complaint in thyroid storm: An
uncommon presentation of graves' disease." Endocrine Reviews 34(3).
Tay, C., et al. (2015). "Surgical management of graves' disease over a 25-year period: A
south-east asian perspective." Thyroid 25: A71-A72.
Thethi, T. K., et al. (2014). "Case of thyrotoxic periodic paralysis in a caucasian male andreview of literature." Case Reports in Medicine 2014.
Thirion, M., et al. (2006). "Thyrotoxicosis." Reanimation 15(6): 497-505.
Thirumalai, A. and S. Trikudanathan (2015). "Radioiodine ablation for amiodaroneinduced thyrotoxicosis allows re-introduction of the drug." Thyroid 25: A217.
Timothy, P. P. and V. Niran (2014). "Incidence of hyperthyroidism in patients exposed toamiodarone shows large regional variation new abstract." Journal of Population
Therapeutics and Clinical Pharmacology 21(2): e287-e288.
Tomisti, L., et al. (2010). "Amiodarone-induced thyrotoxicosis in patients withmultinodular goiter: Type 1 or type 2 AIT?" Endocrine Abstracts 22: P765.
Toni, M., et al. (2016). "Hyperthyroidism." Medicine (Spain) 12(13): 731-741.
Trevisan, T. L., et al. (2016). "Hyperfunctioning thyroid nodule harboring thyroid
carcinoma with progression to bone metastases secreting thyroid hormone: A casereport." Endocrine Reviews 37(2).
Triay, J. and P. Singhal (2010). "Improving the accuracy of clinical diagnosis in
hyperthyroid disorders using ultrasound assessment." Endocrine Abstracts 22: P792.
Truran, P. and S. Aspinall (2014). "Thyrotoxicosis and thyroiditis." Surgery (United
Kingdom) 32(10): 537-542.
Turner, B. C. (2004). "Thyroid emergencies part 1: Thyroid storm." CPD Journal Acute
Medicine 3(3): 93-95.
Ursu, H. I., et al. (2011). "Outcome of radioiodine therapy in autonomous functioning
thyroid nodules-a study group." European Thyroid Journal: 155.
Vallabhajosula, S., et al. (2010). "Hyperthyroidism is associated with reversible
pulmonary hypertension." Journal of Investigative Medicine 58(2): 425.
Viejo, E., et al. (2017). "Emergency surgery in amiodarone-induced thyrotoxicosis."
Langenbeck's Archives of Surgery 402(2): 354.
Vincent, P. J., et al. (2001). "Subtotal thyroidectomy in the management of Grave's
disease." Medical Journal Armed Forces India 57(3): 203-206.
Vitaux, F. (2007). "Thyroid gland irradiations and thyroid cancers. Critical bibliographic
journal." Medecine Nucleaire 31(7): 350-355.

Wada, R., et al. (2013). "A case of fetal hypothyroidism in pregnancy complicated with
Basedow disease." Prenatal Diagnosis 33: 66.
Wang, W. (2016). "Cardiac arrest in a young man from thyroid storm." Journal of General
Internal Medicine 31(2): S575-S576.
Weetman, A. (2009). "Amiodarone-associated hyperthyroidism, a practical guide toinvestigation and therapy." Endocrine Abstracts 19: S58.
Won, K. S., et al. (2015). "Predictive factor for unsuccessful radioactive iodine therapy inpatients with diffuse toxic goiter." Journal of Nuclear Medicine 56.
Xiao, B. Z., et al. (2013). "Incidence of hyperthyroidism in Chongqing City before andafter universal salt iodization." Chinese Journal of Endemiology 32(6): 682-686.
Xu, S. H., et al. (2015). "A questionnaire survey on the management of Graves'
orbitopathy in China: A comparison with Europe and Latin-America." Chronic Diseases
and Translational Medicine 1(2): 117-123.
Yaneva, M. (2015). "Radioiodine therapy outcome in older patients with thyreotoxicosis
caused by Graves' disease : Our experience." European Journal of Nuclear Medicine andMolecular Imaging 42(1): S727.
Yener, S., et al. (2009). "Advance age and mild thyrotoxicosis are associated with nodular
goiter in Graves Disease." Turkish Journal of Endocrinology and Metabolism 13(1): 1-4.
Yoshida, K., et al. (2015). "A case of late-night paralysis of the extremities." Journal of
General Internal Medicine 30: S330-S331.
Yousefian, S., et al. (2014). "Metastatic papillary thyroid carcinoma in a 15-year oldpatient with graves' disease." Endocrine Reviews 35.
Zangana, A. M. (2007). "Surgical treatment of hyperthyroidism in the North of Iraq:
Reduction in mortality and morbidity with a planned approach. Results of 544 operations
with special reference to pre-operative treatment with Carbimazole and thyroid
hormones." Middle East Journal of Emergency Medicine 7(2): 71-75.

Zelada, H., et al. (2016). "In-hospital mortality secondary to methimazole-induced
agranulocytosis." Thyroid 26: A158-A159.
Zhu, G. H., et al. (2010). "Comparison of short-term effects between interventional
embolization treatment and iodine-131 therapy for Graves' hyperthyroidism." Journal ofInterventional Radiology 19(3): 184-187.
Zhu, R. X., et al. (2006). "Evidence-based treatment for a patient with Graves' disease."
Chinese Journal of Evidence-Based Medicine 6(5): 380-384.